The trial that could revolutionise medicine safety

Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.

Addressing Australia’s overdose problem

For the fifth year in a row, more than 2,000 Australians lost their lives to overdose in 2018, according to Australia’s Annual Overdose Report 2020 from Penington Institute.

Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD

Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2

Pharmacists demand equitable remuneration

Pharmacists displayed a united front last week, reaching out to local government members and other healthcare professionals about pharmacist remuneration.

Disordered eating common in people with diabetes

People with diabetes need to constantly monitor their diet and weight, which can lead to a difficult relationship with food.

What pharmacists need to know about nicotine vaping products

Strict legal requirements to dispense nicotine vaping products for smoking cessation are now in use. Here’s what you need to know.